![Caption available](https://unclineberger.org/wp-content/uploads/sites/867/2019/12/mayer-deborah-deb-h_21789625724_o-600x400.jpg)
February 24, 2020
Outside support is key to navigating cancer survivorship
Cancer Transitions is a free cancer survivor workshop open to adult cancer survivors and their caregivers. Experts discuss survivorship and life after treatment.
February 24, 2020
Cancer Transitions is a free cancer survivor workshop open to adult cancer survivors and their caregivers. Experts discuss survivorship and life after treatment.
February 21, 2020
Marjory Charlot, MD, MPH, MSc, associate director for community outreach and engagement for patient-centered research, shares the impact of the Victory Ride.
February 19, 2020
When their daughter was diagnosed with breast cancer, the Chewnings heard more than just a doctor talking about a patient: they heard a physician-scientist looking for answers.
February 14, 2020
Carrie Dobbins, major gifts officer and development director at UNC Lineberger, shares why she is part of the UNC Lineberger team for the Victory Ride to Cure Cancer.
February 13, 2020
Researchers led by Gaorav Gupta, MD, PhD, found that disruption of the Mre11 gene's function plays a key role in the genomic instability of triple negative breast cancer.
February 13, 2020
When traditional cancer treatment options failed, Sabrina Shelton's care team referred her to UNC for a CAR-T therapy clinical trial.
February 11, 2020
Andrew Z. Wang, MD, was corresponding author of a paper evaluating whether nanoparticle drug delivery contributed to liver damage, or hepatotoxicity.
February 11, 2020
UNC Lineberger's Aziz Sancar, MD, PhD, has been named the 2019 recipient of the Hyman L. Battle Distinguished Cancer Research Award.
February 10, 2020
UNC Lineberger's 44th Annual Scientific Symposium will bring together experts to share the latest on the biology of the immune system and cancer.
February 7, 2020
Researchers led by Yuliya Pylayeva-Gupta, PhD, have identified the culprit that keeps cancer-killing immune cells from reaching pancreatic cancer tumors. Their findings were published in the journal Cancer Immunology Research.